Healthcare REITs in Focus as a Long-Term Bet on Aging Demographics
Healthcare REITs like Welltower are benefiting from aging demographics, rising senior housing demand and improving occupancy as new supply stays constrained.
CareTrust REIT: Pullback Improves Long-Term Setup, But I'm Not Ready To Pull The Trigger Yet
CareTrust REIT remains fundamentally strong, but at a forward P/AFFO near 19.0x, I reiterate a hold rating, awaiting a deeper pullback. CTRE delivered robust Q1 results, with FFO up 14% year-over-year and raised 2024 guidance, yet growth may be moderating. Balance sheet strength is exceptional, with net debt/EBITDA at 0.6x and an upgrade to investment-grade, supporting future acquisition capacity.
CareTrust REIT (CTRE) Upgraded to Buy: Here's Why
CareTrust REIT (CTRE) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
CareTrust REIT Remains A Strong Buy After Q1 Results, Driving The Growth Thesis
CareTrust REIT maintains a strong buy rating, supported by robust portfolio growth and favorable senior care demand trends. CTRE demonstrates impressive EBITDA margins above 86%, with analyst consensus forecasting FFO growth this year and next. The REIT outperforms peers in return on equity and has considerable geographic diversification, with notable expansion into the UK market.
CareTrust REIT Q1 Earnings Call Highlights
CareTrust REIT NYSE: CTRE reported a strong start to 2026, highlighting rapid investment activity, higher funds from operations and an increased full-year outlook during its first-quarter earnings call.
CareTrust REIT, Inc. (CTRE) Q1 2026 Earnings Call Transcript
CareTrust REIT, Inc. (CTRE) Q1 2026 Earnings Call Transcript
CareTrust REIT (CTRE) Q1 FFO Meet Estimates
CareTrust REIT (CTRE) came out with quarterly funds from operations (FFO) of $0.48 per share, in line with the Zacks Consensus Estimate . This compares to FFO of $0.42 per share a year ago.
CPC Advisors LLC Takes Position in CareTrust REIT, Inc. $CTRE
CPC Advisors LLC acquired a new stake in CareTrust REIT, Inc. (NYSE: CTRE) in the undefined quarter, according to the company in its most recent 13F filing with the SEC. The firm acquired 163,570 shares of the company's stock, valued at approximately $5,915,000. CPC Advisors LLC owned approximately 0.07% of CareTrust REIT at
The Longevity Economy: Why Healthcare REITs Are in Focus
Ventas highlights how aging demographics are boosting healthcare REIT demand, with senior housing occupancy growth and limited supply supporting long-term growth.
CareTrust REIT: This Overlooked REIT's Hot Streak Continues, But The Bargain Is Gone (Rating Downgrade)
CareTrust REIT is downgraded from buy to hold as its valuation appears stretched despite continued operational outperformance. CTRE delivered double-digit FFO and revenue growth robust acquisition activity and maintains a strong balance sheet with low leverage and high liquidity. Management guides for 9.4% FFO and FAD growth in 2026, with further upside possible if M&A accelerates in a lower-rate environment.
CareTrust REIT: Upgraded As The Senior & Skilled Nursing Niche Keeps Bulls Charging
CareTrust REIT is upgraded to a strong buy, supported by robust portfolio growth, UK expansion, and sector tailwinds from aging demographics. CTRE outperforms peers in five-year revenue CAGR and ROE and a 10-year price return of +246%, beating the S&P 500. Balance sheet risk is conservative with a BBB- Fitch rating, the lowest D/E ratio among peers at 0.22, and diversified geographic exposure, though tenant concentration with Ensign Group is elevated.
CareTrust REIT: Normalized FFO Growth Continues Amid Attractive Investment Spreads
CareTrust REIT is off to a strong start in 2026, supported by a bullish 2026 normalized FFO growth outlook. CTRE expects normalized FFO of $1.90-1.95/share this year, driven by 2025 investments, incremental capital deployment early in 2026, and 2.5% rent indexation. I think the outlook can be revised higher if CTRE makes swift progress on its $500 million investment pipeline. Alternatively, ongoing share issuance may weigh on the outlook.
